XyloCor Therapeutics
Series B
Gene therapy for cardiovascular diseases
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
Founders
R
LinkedIn
News & Funding
Similar Startups
Freenome
Blood test to detect colorectal cancer
Human Longevity
Series B
Early detection for longer life
Kanvas Biosciences
Series A
Gut microbiome for therapeutics
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
SimpliFed
Series A
Baby breastfeeding virtual care
Janux Therapeutics
Immunotherapy to fight tumors